en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank


 
2/2021
vol. 59
 
Share:
Share:
more
 
 
abstract:
Case-based review

Takayasu’s arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?

Amel Rezgui
1
,
Maissa Thabet
1
,
Sahar Makki
1
,
Jihed Anoun
1
,
Imen Ben Hassine
1
,
Monia Karmeni
1
,
Fatma Ben Fredj
1
,
Anis Mzabi
1
,
Chedia Laouani
1

1.
Department of Internal Medicine, Sahloul Hospital, University of Sousse, Faculty of Medicine of Sousse, Tunisia
Reumatologia 2021; 59, 2: 111–114
Online publish date: 2021/02/09
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Coexistence of spondyloarthritis (SpA) and Takayasu’s arteritis is not a common finding, but such cases have been discussed, particularly in the context of choice of therapy. Inhibition of inflammation by tumor necrosis factor inhibitors (TNFi) is a key aspect of the treatment of SpA and also positive effects of such treatment in concomitant large vessel vasculitis have been reported. However, TNFi is also associated with the possibility of initiating vasculitis.

The present article based on a case study and the available literature is an attempt to discuss coexistence of these two diseases and the impact of treatment with biological drugs from the anti-TNF group in the course of SpA with Takayasu’s arteritis.
keywords:

ankylosing spondylitis, Takayasu’s arteritis, tumor necrosis factor







Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.